PPT-After a median 32 months of follow-up, there was no significant difference in the occurrence

However patients receiving febuxostat were a significant 22 more likely to die from any cause than those taking allopurinol with rates of 78 versus 64 and this was

Upload by studyne
Published on 2020-06-17

Presentation Embed Code

<iframe width="560" height="315" src="https://www.docslides.com/embed/779929" frameborder="0" allowfullscreen></iframe>

Download Presentation

Download Presentation The PPT/PDF document "After a median 32 months of follow-up, t..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.